Australia
· Delayed Price · Currency is AUD Ramsay Health Care Statistics
Total Valuation
Ramsay Health Care has a market cap or net worth of 11.47 billion. The enterprise value is 22.34 billion.
| Market Cap | 11.47B |
| Enterprise Value | 22.34B |
Important Dates
The last earnings date was Thursday, February 29, 2024.
| Earnings Date | Feb 29, 2024 |
| Ex-Dividend Date | Mar 11, 2024 |
Share Statistics
Ramsay Health Care has 228.30 million shares outstanding. The number of shares has increased by 0.26% in one year.
| Shares Outstanding | 228.30M |
| Shares Change (YoY) | +0.26% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 21.70% |
| Owned by Institutions (%) | 37.23% |
| Float | 178.84M |
Valuation Ratios
The trailing PE ratio is 55.99 and the forward PE ratio is 23.81. Ramsay Health Care's PEG ratio is 1.66.
| PE Ratio | 55.99 |
| Forward PE | 23.81 |
| PS Ratio | 0.73 |
| Forward PS | n/a |
| PB Ratio | 2.41 |
| P/FCF Ratio | 37.11 |
| PEG Ratio | 1.66 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.85, with an EV/FCF ratio of 71.11.
| EV / Earnings | 25.91 |
| EV / Sales | 1.40 |
| EV / EBITDA | 11.85 |
| EV / EBIT | 26.93 |
| EV / FCF | 71.11 |
Financial Position
The company has a current ratio of 0.95, with a Debt / Equity ratio of 2.29.
| Current Ratio | 0.95 |
| Quick Ratio | 0.78 |
| Debt / Equity | 2.29 |
| Debt / EBITDA | 5.88 |
| Debt / FCF | 35.29 |
| Interest Coverage | 1.45 |
Financial Efficiency
Return on equity (ROE) is 17.84% and return on invested capital (ROIC) is 3.31%.
| Return on Equity (ROE) | 17.84% |
| Return on Assets (ROA) | 4.18% |
| Return on Capital (ROIC) | 3.31% |
| Revenue Per Employee | 181,376 |
| Profits Per Employee | 9,798 |
| Employee Count | 88,000 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 60.35 |
Taxes
In the past 12 months, Ramsay Health Care has paid 146.80 million in taxes.
| Income Tax | 146.80M |
| Effective Tax Rate | 14.55% |
Stock Price Statistics
The stock price has decreased by -17.15% in the last 52 weeks. The beta is 0.66, so Ramsay Health Care's price volatility has been lower than the market average.
| Beta (1Y) | 0.66 |
| 52-Week Price Change | -17.15% |
| 50-Day Moving Average | 53.01 |
| 200-Day Moving Average | 51.77 |
| Relative Strength Index (RSI) | 40.24 |
| Average Volume (30 Days) | 425,161 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ramsay Health Care had revenue of 15.96 billion and earned 862.20 million in profits. Earnings per share was 3.77.
| Revenue | 15.96B |
| Gross Profit | 1.48B |
| Operating Income | 829.30M |
| Pretax Income | 403.30M |
| Net Income | 862.20M |
| EBITDA | 1.88B |
| EBIT | 829.30M |
| Earnings Per Share (EPS) | 3.77 |
Balance Sheet
The company has 361.70 million in cash and 11.08 billion in debt, giving a net cash position of -10.68 billion or -46.78 per share.
| Cash & Cash Equivalents | 361.70M |
| Total Debt | 11.08B |
| Net Cash | -10.68B |
| Net Cash Per Share | -46.78 |
| Equity / Book Value | 4.83B |
| Book Value Per Share | 21.17 |
| Working Capital | -177.70M |
Cash Flow
In the last 12 months, operating cash flow was 1.06 billion and capital expenditures -750.30 million, giving a free cash flow of 314.10 million.
| Operating Cash Flow | 1.06B |
| Capital Expenditures | -750.30M |
| Free Cash Flow | 314.10M |
| FCF Per Share | 1.37 |
Margins
Gross margin is 9.28%, with operating and profit margins of 5.20% and 5.40%.
| Gross Margin | 9.28% |
| Operating Margin | 5.20% |
| Pretax Margin | 2.53% |
| Profit Margin | 5.40% |
| EBITDA Margin | 11.81% |
| EBIT Margin | 5.20% |
| FCF Margin | 1.97% |
Dividends & Yields
This stock pays an annual dividend of 0.65, which amounts to a dividend yield of 1.30%.
| Dividend Per Share | 0.65 |
| Dividend Yield | 1.30% |
| Dividend Growth (YoY) | -55.78% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 17.24% |
| Buyback Yield | -0.26% |
| Shareholder Yield | 1.01% |
| Earnings Yield | 7.40% |
| FCF Yield | 2.69% |
Analyst Forecast
| Price Target | 57.02 |
| Price Target Difference | 13.68% |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |